Effect of memantine on the α7 neuronal nicotinic receptors, synaptophysin- and low molecular weight MAP-2 levels in the brain of transgenic mice over-expressing human acetylcholinesterase

Journal of Neural Transmission

Volumn 112, Issue 2, 2005, Pages 255-268

  Unger, C ^a   Svedberg, M M ^a   Schutte, M ^a   Bednar, I ^a   Nordberg, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

7 nAChR; hAChE Tg; MAP 2; Memantine; NMDA receptors; Synaptophysin

Indexed keywords

ACETYLCHOLINESTERASE; MEMANTINE; MICROTUBULE ASSOCIATED PROTEIN 2; NICOTINIC RECEPTOR; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; EVALUATION; FRONTAL CORTEX; GENE OVEREXPRESSION; MOLECULAR WEIGHT; MOUSE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; TRANSGENIC MOUSE;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MEMANTINE; MICE; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; PROTEIN BINDING; RECEPTORS, NICOTINIC; SYNAPTOPHYSIN;

EID: 13144293075     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-004-0183-2     Document Type: Article

References (51)

1. Aigner TG (1995) Pharmacology of memory: cholinergic-glutamatergic interactions. Curr Opin Neurobiol 5: 155-160
2. Albuquerque EX, Alkondon M, Pereira EF, Castro NG, Schrattenholz A, Barbosa CT, Bonfante-Cabarcas R, Aracava Y, Eisenberg HM, Maelicke A (1997) Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther 280: 1117-1136
3. Alexa A, Tompa P, Baki A, Vereb G, Friedrich P (1996) Mutual protection of microtubule-associated protein 2 (MAP2) and cyclic AMP-dependent protein kinase II against mucalpain. J Neurosci Res 44: 438-445
4. Alvarez A, Opazo C, Alarcon R, Garrido J, Inestrosa NC (1997) Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. J Mol Biol 272: 348-361
5. Alvarez A, Alarcon R, Opazo C, Campos EO, Munoz FJ, Calderon FH, Dajas F, Gentry MK, Doctor BP, De Mello FG, Inestrosa NC (1998) Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J Neurosci 18: 3213-3223
6. Beeri R, Andres C, Lev-Lehman E, Timberg R, Huberman T, Shani M, Soreq H (1995) Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr Biol 5: 1063-1071
7. Beeri R, Le Novere N, Mervis R, Huberman T, Grauer E, Changeux JP, Soreq H (1997) Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J Neurochem 69: 2441-2451
8. Binder LI, Frankfurter A, Kim H, Cáceres A, Payne MR, Rebhun LI (1984) Heterogeneity of microtubule-associated protein 2 during rat brain development. PNAS 81: 5613-5617
9. Buisson B, Bertrand D (1998) Open-Channel blockers at the human α4β2 neuroal nicotinic acetylcholine receptor. Mol Pharmacol 53: 555-563
10. Calderon FH, von Bernhardi R, De Ferrari G, Luza S, Aldunate R, Inestrosa NC (1998) Toxic effects of acetylcholinesterase on neuronal and glial-like cells in vitro. Mol Psychiatry 3: 247-255
11. De Ferrari GV, Canales MA, Shin I, Weiner LM, Silman I, Inestrosa NC (2001) A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation. Biochemistry 40: 10447-10457
12. Erb C, Troost J, Kopf S, Schmitt U, Loffelholz K, Soreq H, Klein J (2001) Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J Neurochem 77: 638-646
13. Felipo V, Grau E, Minana MD, Grisolia S (1993) Ammonium injection induces an N-methyl-D-aspartate receptor-mediated proteolysis of the microtubule-associated protein MAP-2. J Neurochem 60: 1626-1630
14. Fisher JL, Dani JA (2000) Nicotinic receptors on hippocampal cultures can increase synaptic glutamate currents while decreasing the NMDA-receptor component. Neuropharmacology 39: 2756-2769
15. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383: 713-716
16. Greenamyre JT, Maragos WF (1993) Neurotransmitter receptors in Alzheimer disease. Cerebrovasc Brain Metab Rev 5: 61-94
17. Hoog A, Gould VE, Grimelius L, Franke WW, Falkmer S, Chejfec G (1988) Tissue fixation methods alter the immunohistochemical demonstrability of synaptophysin. Ultrastruct Pathol 12: 673-678
18. Johnson GV, Jope RS (1992) The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration. J Neurosci Res 33: 505-512
19. Jonnala RR, Buccafusco JJ (2001) Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. J Neurosci Res 66: 565-572
20. Kemp JA, McKernan RM (2002) NMDA receptor pathways as drug targets. Nat Neurosci 5 [Suppl]: 1039-1042
21. Lowe SL, Bowen DM, Francis PT, Neary D (1990) Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neuroscience 38: 571-577
22. Marchi M, Risso F, Viola C, Cavazzani P, Raiteri M (2002) Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J Neurochem 80: 1071-1078
23. Maskell PD, Speder P, Newberry NR, Bermudez I (2003) Inhibition of human α7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors. Br J Pharmacol 140: 1313-1319
24. Matus A (1988) Microtubule-associated proteins: their potential role in determining neuronal morphology. Annu Rev Neurosci 11: 29-44
25. Matus A (1994) Stiff microtubules and neuronal morphology. Trends Neurosci 17: 19-22
26. Maurice T, Hiramatsu M, Itoh J, Kameyama T, Hasegawa T, Nabeshima T (1994) Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res 647: 44-56
27. McGehee DS, Heath MJ, Gelber S, Devay P, Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269: 1692-1696
28. Meldrum B, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11: 379-387
29. Miñana MD, Montoliu C, Llansola M, Grisolia S, Felipo V (1998) Nicotine prevents glutamate-induced proteolysis of the microtubule-associated protein MAP-2 and glutamate neurotoxicity in primary cultures of cerebellar neurons. Neuropharmacology 37: 847-857
30. Nordberg A (1999) PET studies and cholinergic therapy in Alzheimer's disease. Rev Neurol (Paris) 155 [Suppl 4]: S53-S63
31. Nordberg A (2001) Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol Psychiatry 49: 200-210
32. Ohno M, Yamamoto T, Watanabe S (1993) Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats. Pharmacol Biochem Behav 45: 89-93
33. Okuyama N, Takagi N, Kawai T, Miyake-Takagi K, Takeo S (2004) Phosphorylation of extracellular-regulating kinase in NMDA receptor antagonist-induced newly generated neurons in the adult rat dentate gyrus. J Neurochem 88(3): 717-725
34. Oliver D, Ludwig J, Reisinger E, Zoellner W, Ruppersberg P, Fakler F (2001) Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells. Mol Pharmacol 60: 183-189
35. Paterson D, Nordberg A (2000) Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61: 75-111
36. Perry E, Martin-Ruiz C, Lee M, Griffiths M, Johnson M, Piggott M, Haroutunian V, Buxbaum JD, Nasland J, Davis K, Gotti C, Clementi F, Tzartos S, Cohen O, Soreq H, Jaros E, Perry R, Ballard C, McKeith I, Court J (2000) Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. Eur J Pharmacol 393: 215-222
37. Procter AW, Francis PT, Lowe SL, Pangalos MN, Steele JE, Bowen DM (1990) Clinical correlations of the neurobiological changes of aging. Ann Med Interne (Paris) 141 [Suppl 1]: 3-6
38. Radcliffe KA, Dani JA (1998) Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission. J Neurosci 18: 7075-7083
39. Radcliffe KA, Fisher JL, Gray R, Dani JA (1999) Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons. Ann NY Acad Sci 868: 591-610
40. Rammes G, Rupprecht R, Ferrari U, Zieglgansberger W, Parsons CG (2001) The N-methyl-D-aspartale receptor channel blocker memantine, MRZ 2/579 and other amino-alkyl-cyklohexanes anlagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Lett 306: 81-84
41. Rees T, Hammond PI, Soreq H, Younkin S, Brimijoin S (2003) Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol Aging 24: 777-787
42. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ (2003) Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348: 1333-1341
43. Riederer B, Matus A (1985) Differential expression of distinct microtubule-associated protein during brain development. PNAS 82: 6006-6009
44. Soreq H, Seidman S (2001) Acetylcholinesterase - new roles for an old actor. Nat Rev Neurosci 2: 294-302
45. Sternfeld M, Shoham S, Klein O, Flores-Flores C, Evron T, Idelson GH, Kitsberg D, Patrick JW, Soreq H (2000) Excess "read-through" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. Proc Natl Acad Sci USA 97: 8647-8652
46. Svedberg MM, Svensson AL, Johnson M, Lee M, Cohen O, Court J, Soreq H, Perry E, Nordberg A (2002) Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase. J Mol Neurosci 18: 211-222
47. Svedberg MM, Svensson AL, Bednar I, Nordberg A (2003) Neuronal nicotinic and muscarinic receptor subtypes at different ages of transgenic mice overexpressing human acetylcholinesterase. Neurosci Lett 340: 148-152
48. Toggas SM, Masliah E, Mucke L (1996) Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 706: 303-307
49. Tucker RP (1990) The roles of microtubule-associated proteins in brain morphogenesis: a review. Brain Res Rev 15: 101-120
50. Wenk GL, Zajaczkowski W, Danysz W (1997) Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B. Behav Brain Res 83(1-2): 129-133
51. Zajaczkowski W, Quack G, Danysz W (1996) Infusion of (+) -MK-801 and memantine - contrasting effects on radial maze learning in rats with entorhinal cortex lesion. Eur J Pharmacol 296: 239-246